The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use... Sep 23
Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection ... Jul 31
-Advertisements-